Top section
Top section
Streamlining of IPO process just two months after consultation closed as the market prepares for post-summer IPO activity
Sale comes after the expiry last month of a pre-emptive acquisition rights agreement between the main family holding companies
Placing and open offer follows recent acquisition of US annuity provider
More articles
More articles
More articles
-
The coronavirus pandemic is causing many unintended consequences for working practices in the capital markets. One welcome development could be a shake-up in the way European IPOs are run and managed, which is long overdue. -
Adaptimmune Therapeutics, the New York-listed UK biopharmaceutical company focused on cancer treatments, has raised $225m to fund further clinical trials for its immunotherapy treatments.
-
The reopening of Italian equity capital markets gathered pace on Monday night with two block trades with sellers across Europe expected to take advantage of the market conditions with further trades
-
China Meidong Auto Holdings turned to investors on Tuesday for up to HK$1.01bn ($130.4m) from a top-up placement, according to a source familiar with the matter.
-
The board of directors at Mahindra and Mahindra Financial Services has approved plans for a potential Rp35bn ($463.5m) rights issue.
-
China’s Dada Nexus, an operator of on-demand retail and delivery platforms, has launched bookbuilding for its up to $280.5m US listing, according to a source familiar with the matter.
Sub-sections
shared comment list
